Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) - part III

ABSTRACT:

ORGANISM(S): Homo Sapiens

TISSUE(S): Cultured Cells

DISEASE(S): Fatty Liver Disease

PROVIDER: ST000680 | MetabolomicsWorkbench |

REPOSITORIES: MetabolomicsWorkbench

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	mwtab	Other

Items per page:

1 - 1 of 1

Similar Datasets

Metabolomics Workbench ST000680 - GNPS - Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) - part III

Project description:In this experiment, vector , GCKR (WT), GCKR(P446L), PPP1R3B, TM6SF2 (WT and E167K) overexpression stable HuH-7_Lok cell lines as well as Non-target, GCKR shRNA (52621), PPP1R3B shRNA (2640), TM6SF2 shRNA (382426) knockdown HuH-7_Lok cell lines are used to do the lipidomics experiments 3 X 100 mm dishes of cells were seeded (1x106 cells/dish) for each cell line and incubated at 37? C for 24 hours, then replaced medium with delipidated serum DMEM medium. After 24 hours, treated with BSA-OA (200?M) for another 24 hours before the collection of cells Add 4mL/dish 50 mM ammonium acetate wash cells and then quench cells by adding liquid nitrogen covering all the surface of dish. Store the cell samples in -80?C freezer.

2018-08-02 | MSV000082706 | GNPS

Functional genomics study on Non Alcoholic fatty liver disease (NAFLD)

Project description: Not available

| ST000678 | MetabolomicsWorkbench

Project description: Not available

| S-EPMC9496390 | biostudies-literature

Animal study to validate effects of ACOT1 in Non-alcoholic Fatty Liver Disease (NAFLD)

Project description:6-8-week-old male C57BL/6 were divided into 2 groups after 12 weeks on the HFD diet, and tail vein injections of either an Adenoviral vector (with Adenoviral type 5 backbone) containing Ad-GFP-m-ACOT1 or Ad-GFP at 1x109 PFU were performed weekly for 4 weeks

2021-05-21 | GSE174797 | GEO

Metabolomics Workbench ST000679 - GNPS - Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) - part II

2018-08-02 | MSV000082695 | GNPS

Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD).

Project description: Not available

| S-EPMC1954961 | biostudies-literature

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD).

Project description: Not available

| S-EPMC9884828 | biostudies-literature

Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD).

Project description: Not available

| S-EPMC7724177 | biostudies-literature

Animal study to validate effects of ACOT1 silencing in Non-alcoholic Fatty Liver Disease (NAFLD)

Project description:6-8-week-old male C57BL/6 were divided into 2 groups after 12 weeks on the HFD diet, and tail vein injections of an Adenoviral vector containing Ad-GFP-U6-scramble-shRNA or Ad-GFP-U6-m-ACOT1-shRNA at 1x109 PFU were performed weekly for 6 weeks (Vector Biolabs)

2021-05-25 | GSE175426 | GEO

Phenotypes of non-alcoholic fatty liver disease (NAFLD) and all-cause mortality: unsupervised machine learning analysis of NHANES III.

Project description: Not available

| S-EPMC9685238 | biostudies-literature